Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Danaher Corporation designs, manufactures, and markets professional, medical, industrial and commercial products, and services in the sectors of test and measurement, environmental, life sciences, dental, and industrial technologies.
Website: danaher.com


  • Bad financial results growth rate -13.2% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (-4.7%)
  • Dividend yield for the last twelve months 0.6%
  • Free cash flow yield 1.0% (LTM)
  • Share price is 20.1% higher than minimum and 30.6% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (32.4x vs
    )
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: DHR
Share price, USD:  (+0.3%)209.7825
year average price 223.61  


year start price 269.33 2024-08-15

max close price 278.02 2024-09-30

min close price 174.64 2025-04-08

current price 209.93 2025-08-14
Common stocks: 727 076 992

Dividend Yield:  0.6%
FCF Yield LTM: 1.0%
EV / LTM EBITDA: 32.4x
EV / EBITDA annualized: 44.0x
Last revenue growth (y/y):  +3.4%
Last growth of EBITDA (y/y):  -29.8%
Historical revenue growth:  +0.6%
Historical growth of EBITDA:  -10.1%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 152 528
Net Debt ($m): 14 406
EV (Enterprise Value): 166 934
EBITDA LTM ($m): 5 147
EV / LTM EBITDA: 32.4x
Price to Book: 3.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-08-12businesswire.com

EQUITY ALERT: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

2025-08-11zacks.com

CVS or DHR: Which Is the Better Value Stock Right Now?

2025-07-28zacks.com

International Markets and Danaher (DHR): A Deep Dive for Investors

2025-07-24youtube.com

Investors decided the good outweighs the bad with Danaher, says Jim Cramer

2025-07-24seekingalpha.com

Danaher Q2 2025 Update

2025-07-24zacks.com

CVS or DHR: Which Is the Better Value Stock Right Now?

2025-07-23seekingalpha.com

Danaher Stock: Attractively Valued And Poised For Growth Acceleration

2025-07-22zacks.com

Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y

2025-07-22zacks.com

Danaher (DHR) Q2 Earnings and Revenues Top Estimates

2025-07-22prnewswire.com

Danaher Announces Transition Plan for Chief Financial Officer
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data